Your browser doesn't support javascript.
loading
EBF1-JAK2 inhibits the PAX5 function through physical interaction with PAX5 and kinase activity.
Kojima, Yukino; Kawashima, Fumika; Yasuda, Takahiko; Odaira, Koya; Inagaki, Yuichiro; Yamada, Chiharu; Muraki, Ami; Noura, Mina; Okamoto, Shuichi; Tamura, Shogo; Iwamoto, Eisuke; Sanada, Masashi; Matsumura, Itaru; Miyazaki, Yasushi; Kojima, Tetsuhito; Kiyoi, Hitoshi; Tsuzuki, Shinobu; Hayakawa, Fumihiko.
Afiliação
  • Kojima Y; Division of Cellular and Genetic Sciences, Department of Integrated Health Sciences, Nagoya University Graduate School of Medicine, 1-1-20 Daiko-Minami, Higashi-ku, Nagoya, 461-0047, Japan.
  • Kawashima F; Division of Cellular and Genetic Sciences, Department of Integrated Health Sciences, Nagoya University Graduate School of Medicine, 1-1-20 Daiko-Minami, Higashi-ku, Nagoya, 461-0047, Japan.
  • Yasuda T; Clinical Research Center, National Hospital Organization Nagoya Medical Center, Nagoya, Japan.
  • Odaira K; Division of Cellular and Genetic Sciences, Department of Integrated Health Sciences, Nagoya University Graduate School of Medicine, 1-1-20 Daiko-Minami, Higashi-ku, Nagoya, 461-0047, Japan.
  • Inagaki Y; Department of Hematology and Oncology, Anjo Kosei Hospital, Anjo, Japan.
  • Yamada C; Division of Cellular and Genetic Sciences, Department of Integrated Health Sciences, Nagoya University Graduate School of Medicine, 1-1-20 Daiko-Minami, Higashi-ku, Nagoya, 461-0047, Japan.
  • Muraki A; Division of Cellular and Genetic Sciences, Department of Integrated Health Sciences, Nagoya University Graduate School of Medicine, 1-1-20 Daiko-Minami, Higashi-ku, Nagoya, 461-0047, Japan.
  • Noura M; Division of Cellular and Genetic Sciences, Department of Integrated Health Sciences, Nagoya University Graduate School of Medicine, 1-1-20 Daiko-Minami, Higashi-ku, Nagoya, 461-0047, Japan.
  • Okamoto S; Division of Cellular and Genetic Sciences, Department of Integrated Health Sciences, Nagoya University Graduate School of Medicine, 1-1-20 Daiko-Minami, Higashi-ku, Nagoya, 461-0047, Japan.
  • Tamura S; Division of Cellular and Genetic Sciences, Department of Integrated Health Sciences, Nagoya University Graduate School of Medicine, 1-1-20 Daiko-Minami, Higashi-ku, Nagoya, 461-0047, Japan.
  • Iwamoto E; Clinical Research Center, National Hospital Organization Nagoya Medical Center, Nagoya, Japan.
  • Sanada M; Clinical Research Center, National Hospital Organization Nagoya Medical Center, Nagoya, Japan.
  • Matsumura I; Department of Hematology and Rheumatology, Kindai University School of Medicine, Osaka, Japan.
  • Miyazaki Y; Department of Hematology, Atomic Bomb Disease and Hibakusha Medicine Unit, Atomic Bomb Disease Institute, Nagasaki University, Nagasaki, Japan.
  • Kojima T; Division of Cellular and Genetic Sciences, Department of Integrated Health Sciences, Nagoya University Graduate School of Medicine, 1-1-20 Daiko-Minami, Higashi-ku, Nagoya, 461-0047, Japan.
  • Kiyoi H; Aichi Health Promotion Foundation, Nagoya, Japan.
  • Tsuzuki S; Department of Hematology and Oncology, Nagoya University Graduate School of Medicine, Nagoya, Japan.
  • Hayakawa F; Department of Biochemistry, Aichi Medical University School of Medicine, Nagakute, Japan.
Int J Hematol ; 118(1): 65-74, 2023 Jul.
Article em En | MEDLINE | ID: mdl-37149540

Texto completo: 1 Coleções: 01-internacional Temas: Geral Base de dados: MEDLINE Assunto principal: Fatores de Transcrição STAT / Janus Quinases Limite: Humans Idioma: En Revista: Int J Hematol Assunto da revista: HEMATOLOGIA Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Japão

Texto completo: 1 Coleções: 01-internacional Temas: Geral Base de dados: MEDLINE Assunto principal: Fatores de Transcrição STAT / Janus Quinases Limite: Humans Idioma: En Revista: Int J Hematol Assunto da revista: HEMATOLOGIA Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Japão